ROBERTO, MICHELA
ROBERTO, MICHELA
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine
2020 Botticelli, A.; Scagnoli, S.; Roberto, M.; Lionetto, L.; Cerbelli, B.; Simmaco, M.; Marchetti, P.
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
2016 Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
[Immunotherapy in non-small cell lung cancer patients: back to the future.]
2019 Roberto, Michela; Botticelli, Andrea; Cecere, Sabrina; Cognetti, Francesco; Giusti, Raffaele; Gelibter, Alain; Nelli, Fabrizio; Nuti, Marianna; Santini, Daniele; Marchetti, Paolo
A 17-gene expression signature for early identification of poor prognosis in clear cell renal cell carcinoma
2022 Bassanelli, M.; Borro, M.; Roberto, M.; Giannarelli, D.; Giacinti, S.; Di Martino, S.; Ceribelli, A.; Russo, A.; Aschelter, A.; Scarpino, S.; Montori, A.; Pescarmona, E.; Tomao, S.; Simmaco, M.; Cognetti, F.; Milella, M.; Marchetti, P.
A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer
2021 Piras, Marta; Panebianco, Martina; Garibaldi, Matteo; Roberto, Michela; Merlonghi, Gioia; Pellegrini, Patrizia; Marchetti, Paolo
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer
2015 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient
2017 Botticelli, Andrea; Onesti, CONCETTA ELISA; Strigari, Lidia; Occhipinti, Mario; DI PIETRO, FRANCESCA ROMANA; Cerbelli, Bruna; Petremolo, Antonella; Anselmi, Elisabetta; Macrini, Serena; Roberto, Michela; Falcone, Rosa; Lionetto, Luana; Borro, Marina; Milano, Annalisa; Gentile, Giovanna; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
2019 Botticelli, A.; Salati, M.; Di Pietro, F. R.; Strigari, L.; Cerbelli, B.; Zizzari, I. G.; Giusti, R.; Mazzotta, M.; Mazzuca, F.; Roberto, M.; Vici, P.; Pizzuti, L.; Nuti, M.; Marchetti, P.
A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy
2019 Parisi, A.; Cortellini, A.; Roberto, M.; Venditti, O.; Santini, D.; Dell’Aquila, E.; Stellato, M.; Marchetti, P.; Occhipinti, M.; Zoratto, F.; Mazzuca, F.; Tinari, N.; De Tursi, M.; Iezzi, L.; Natoli, C.; Ratti, M.; Pizzo, C.; Ghidini, M.; Ficorella, C.; Cannita, K.
A tricky singular papular peri‐cicatricial mammarian lesion
2024 Cantisani, Carmen; Trovato, Federica; Gargano, Luca; Di Guardo, Antonio; Vasile, Alexandru Bâja; Rovaldi, Emanuele; Azzella, Giulia; Speranza, Iolanda; Soda, Giuseppe; Roberto, Michela; Lettera, Tiziana; Pellacani, Giovanni
Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma
2018 Falcone, Rosa; Roberto, Michela; Filetti, Marco; Anselmi, Elisabetta; Marchetti, Paolo
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial
2016 Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study
2015 Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P.
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer?
2013 Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer. Potential molecular mechanisms, clinical implications and future perspectives
2021 Roberto, M.; Astone, A.; Botticelli, A.; Carbognin, L.; Cassano, A.; D'Auria, G.; Fabbri, A.; Fabi, A.; Gamucci, T.; Krasniqi, E.; Minelli, M.; Orlandi, A.; Pantano, F.; Paris, I.; Pizzuti, L.; Portarena, I.; Salesi, N.; Scagnoli, S.; Scavina, P.; Tonini, G.; Vici, P.; Marchetti, P.
Circulating tumor cells count predicts survival in colorectal cancer patients.
2014 Romiti, Adriana; Raffa, Salvatore; R., Di Rocco; Roberto, Michela; Milano, Annalisa; A., Zullo; Leone, Laura; Ranieri, Danilo; F., Mazzetta; E., Medda; I., Sarcina; Barucca, Viola; C., D'Antonio; V., Durante; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study
2019 Mazzuca, F; Roberto, M; Arrivi, G; Sarfati, E; Schipilliti, Fm; Crimini, E; Botticelli, A; Di Girolamo, M; Muscaritoli, M; Marchetti, P
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study
2019 Mazzuca, F.; Roberto, M.; Arrivi, G.; Sarfati, E.; Schipilliti, F. M.; Crimini, E.; Botticelli, A.; Di Girolamo, M.; Muscaritoli, M.; Marchetti, P.
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma
2015 Roberto, Michela; Bassanelli, Maria; Iannicelli, Elsa; Giacinti, Silvana; D'Antonio, Chiara; Aschelter, Anna Maria; Marchetti, Paolo
clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging”
2013 Romiti, A; Milano, Annalisa; Balducci, G; Ferri, M; Roberto, Michela; D’Antonio, C; Durante, V; Mazzuca, F; Marchetti, P; Ziparo, V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine | 2020 | Botticelli, A.; Scagnoli, S.; Roberto, M.; Lionetto, L.; Cerbelli, B.; Simmaco, M.; Marchetti, P. | |
| 5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX | 2016 | Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| [Immunotherapy in non-small cell lung cancer patients: back to the future.] | 2019 | Roberto, Michela; Botticelli, Andrea; Cecere, Sabrina; Cognetti, Francesco; Giusti, Raffaele; Gelibter, Alain; Nelli, Fabrizio; Nuti, Marianna; Santini, Daniele; Marchetti, Paolo | |
| A 17-gene expression signature for early identification of poor prognosis in clear cell renal cell carcinoma | 2022 | Bassanelli, M.; Borro, M.; Roberto, M.; Giannarelli, D.; Giacinti, S.; Di Martino, S.; Ceribelli, A.; Russo, A.; Aschelter, A.; Scarpino, S.; Montori, A.; Pescarmona, E.; Tomao, S.; Simmaco, M.; Cognetti, F.; Milella, M.; Marchetti, P. | |
| A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer | 2021 | Piras, Marta; Panebianco, Martina; Garibaldi, Matteo; Roberto, Michela; Merlonghi, Gioia; Pellegrini, Patrizia; Marchetti, Paolo | |
| A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer | 2015 | Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo | |
| A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient | 2017 | Botticelli, Andrea; Onesti, CONCETTA ELISA; Strigari, Lidia; Occhipinti, Mario; DI PIETRO, FRANCESCA ROMANA; Cerbelli, Bruna; Petremolo, Antonella; Anselmi, Elisabetta; Macrini, Serena; Roberto, Michela; Falcone, Rosa; Lionetto, Luana; Borro, Marina; Milano, Annalisa; Gentile, Giovanna; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab | 2019 | Botticelli, A.; Salati, M.; Di Pietro, F. R.; Strigari, L.; Cerbelli, B.; Zizzari, I. G.; Giusti, R.; Mazzotta, M.; Mazzuca, F.; Roberto, M.; Vici, P.; Pizzuti, L.; Nuti, M.; Marchetti, P. | |
| A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy | 2019 | Parisi, A.; Cortellini, A.; Roberto, M.; Venditti, O.; Santini, D.; Dell’Aquila, E.; Stellato, M.; Marchetti, P.; Occhipinti, M.; Zoratto, F.; Mazzuca, F.; Tinari, N.; De Tursi, M.; Iezzi, L.; Natoli, C.; Ratti, M.; Pizzo, C.; Ghidini, M.; Ficorella, C.; Cannita, K. | |
| A tricky singular papular peri‐cicatricial mammarian lesion | 2024 | Cantisani, Carmen; Trovato, Federica; Gargano, Luca; Di Guardo, Antonio; Vasile, Alexandru Bâja; Rovaldi, Emanuele; Azzella, Giulia; Speranza, Iolanda; Soda, Giuseppe; Roberto, Michela; Lettera, Tiziana; Pellacani, Giovanni | |
| Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma | 2018 | Falcone, Rosa; Roberto, Michela; Filetti, Marco; Anselmi, Elisabetta; Marchetti, Paolo | |
| Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial | 2016 | Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano | |
| Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study | 2015 | Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P. | |
| cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? | 2013 | Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
| Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer. Potential molecular mechanisms, clinical implications and future perspectives | 2021 | Roberto, M.; Astone, A.; Botticelli, A.; Carbognin, L.; Cassano, A.; D'Auria, G.; Fabbri, A.; Fabi, A.; Gamucci, T.; Krasniqi, E.; Minelli, M.; Orlandi, A.; Pantano, F.; Paris, I.; Pizzuti, L.; Portarena, I.; Salesi, N.; Scagnoli, S.; Scavina, P.; Tonini, G.; Vici, P.; Marchetti, P. | |
| Circulating tumor cells count predicts survival in colorectal cancer patients. | 2014 | Romiti, Adriana; Raffa, Salvatore; R., Di Rocco; Roberto, Michela; Milano, Annalisa; A., Zullo; Leone, Laura; Ranieri, Danilo; F., Mazzetta; E., Medda; I., Sarcina; Barucca, Viola; C., D'Antonio; V., Durante; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo | |
| Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study | 2019 | Mazzuca, F; Roberto, M; Arrivi, G; Sarfati, E; Schipilliti, Fm; Crimini, E; Botticelli, A; Di Girolamo, M; Muscaritoli, M; Marchetti, P | |
| Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study | 2019 | Mazzuca, F.; Roberto, M.; Arrivi, G.; Sarfati, E.; Schipilliti, F. M.; Crimini, E.; Botticelli, A.; Di Girolamo, M.; Muscaritoli, M.; Marchetti, P. | |
| Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma | 2015 | Roberto, Michela; Bassanelli, Maria; Iannicelli, Elsa; Giacinti, Silvana; D'Antonio, Chiara; Aschelter, Anna Maria; Marchetti, Paolo | |
| clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging” | 2013 | Romiti, A; Milano, Annalisa; Balducci, G; Ferri, M; Roberto, Michela; D’Antonio, C; Durante, V; Mazzuca, F; Marchetti, P; Ziparo, V. |